OUSW Drug Demand Reduction Quality Assurance Services

SOL #: DB052920261012Sources Sought

Overview

Buyer

DEPT OF DEFENSE
Washington Headquarters Services (Whs)
WASHINGTON HEADQUARTERS SERVICES
WASHINGTON, DC, 203011000, United States

Place of Performance

Place of performance not available

NAICS

Testing Laboratories and Services (541380)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
May 29, 2026
2
Response Deadline
Jun 30, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Defense (DoD), through Washington Headquarters Services/Acquisition Directorate (WHS/AD), is conducting market research via a Sources Sought Notice/Request for Information (RFI) for Drug Demand Reduction Program (DDRP) Quality Assurance (QA) Support Services for the Office of the Under Secretary of War for Personnel & Readiness (OUSW(P&R)), Office of Drug Demand Reduction (ODDR). This RFI aims to identify qualified firms capable of ensuring the DoD's military drug testing program is forensically sound and efficient. Responses are due June 30, 2026.

Scope of Work

The required services, detailed in the Draft Performance Work Statement (PWS), include:

  • Forensic Toxicology QA Support: Ensuring the integrity of the DoD drug testing program.
  • Proficiency Testing: Managing open and blind proficiency testing programs for five joint-service military drug testing laboratories (FTDTLs), including specimen handling, distribution, and results analysis.
  • Inspections and Evaluations: Conducting accreditation inspections of FTDTLs, with coordination, documentation, and trend analysis.
  • Reference Materials: Manufacturing, distributing, and analyzing reference materials for quality control and method validation.
  • Consultation Services: Providing scientific consultation on forensic requirements, instrumentation, testing methodologies, and interference testing.
  • Financial Management: Developing and maintaining financial management databases and analysis tools.

Contract & Timeline

  • Opportunity Type: Sources Sought / Request for Information (RFI) - Market Research Only.
  • Anticipated Contract Type: Hybrid, including Firm Fixed Price (FFP), Contract Line Items (CLINs) for daily supplies, and optional Time and Material (T&M) CLINs.
  • Anticipated Period of Performance: A 60-day phase-in, one 12-month base period, and four 12-month option periods.
  • Anticipated Contract Value: Approximately $6M (for base + 4 options).
  • Anticipated Award/Start Date: January 2027.
  • Place of Performance: Primarily at the Contractor's primary site, with some tasks at Government facilities.
  • Product Service Code (PSC): Q301 (Reference Laboratory Testing).
  • Anticipated NAICS Codes: 621511 (Medical Laboratories) and/or 541380 (Testing Laboratories and Services).
  • Set-Aside: None specified; responses encouraged from all interested sources, including small businesses and socioeconomic concerns.

Submission & Evaluation

  • Submission Deadline: June 30, 2026, at 10:00 AM (Eastern).
  • Submission Method: Email Capabilities Statement to whs.ncr.ad.mbx.eosd-tab-branch@mail.mil.
  • Capabilities Statement: Limited to 10 pages (excluding supplemental information) and must address specific questions outlined in the RFI.
  • Evaluation: Responses will inform the government's market research regarding industry capabilities and potential small business participation. This is not a solicitation for proposals.

Special Requirements

  • Personnel: Key personnel, including the Program Manager, must meet specific qualifications and may require Secret clearance.
  • Quality Control: Contractors must develop and adhere to a Quality Control Plan (QCP).
  • Compliance: Adherence to Federal laws, ANSI/ASB standard 153-23, AAFS, ABFT, DDRP, DoD Instructions, FAR clauses, and other relevant standards is mandatory.
  • Conflict of Interest: Contractors must identify and mitigate any organizational or personal conflicts of interest.
  • Supplemental Information: Firms are requested to provide suggested PWS changes, identify restrictive information, estimate RFP response time, detail transition period needs, risk assessment, inspector pool size, suggested NAICS/PSC codes, recommended contract type, and commercial availability assessment.

People

Points of Contact

Syreeta DONALDPRIMARY
Daniel BaskinSECONDARY

Files

Files

Download
Download

Versions

Version 1Viewing
Sources Sought
Posted: May 29, 2026
OUSW Drug Demand Reduction Quality Assurance Services | GovScope